Morgan Stanley Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $650

Morgan Stanley analyst Tejas Savant maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $620 to $650.